[Pharmacological properties and clinical efficacy of bempedoic acid (NEXLETOL® tablets 180 mg) for the treatment of hypercholesterolemia].
Bempedoic acid (Nexletol®) is a novel cholesterol-lowering agent that is converted to its active CoA ester by very long-chain acyl-CoA synthetase 1 (ACSVL1), an enzyme selectively expressed in hepatocytes. The active metabolite selectively inhibits ATP citrate lyase (ACL), leading to a reduction in cytosolic acetyl-CoA...